Skip to main content
. Author manuscript; available in PMC: 2021 Feb 25.
Published in final edited form as: Alcohol Clin Exp Res. 2020 May 14;44(6):1164–1174. doi: 10.1111/acer.14332

Table 5.

Results of PRISMA Showing the Impact of Perinatal Marijuana and Perinatal Alcohol in the Hippocampal Formation of Adult Rats and Mice. A/M Indicates if the Perinatal Exposure is Alcohol(A) or Marijuana(M). M and F in the “Main Finding” Column Indicate When There are Sex Differences in the Results. Exposure and Test Ages are Reported as Embryonic (E) Days of Age or Postnatal (P) Days of Age.

A/M Exposure Age Model Sex Test Age What was Investigated? Marker/ Stain Used Hippocampal Subregion Main Finding
1 A P2-P9 Mouse MF P90 GABA Interneurons Venus-VGAT CA1 Decreased in M
CA3 Decreased in M
GCL Decreased in MF
Hilus Decreased in M
2 A E7-E21 Rat M P60 Type 2b INP to Immature Granule Neuron DCX CA1
CA2 + 3
No Change
No Change
DG No Change
3 M E10.5–E17.5 Mouse MF P20-P60 Cannabinoid receptor type 1 CB1R CA1 Decrease in M
Cholecystokinin interneurons CCK CA1 Decrease in M
4 A E1–21 Rat M P78–82 Dividing Cells BrdU DG No Change
Type 2b INP to IGN DCX DG No Change
Dividing Cells Ki-67 DG No Change
P115 Dividing Cells BrdU, P80 DG Decrease
Type 2b INP to IGN DCX DG No Change
5 A E1-P9 Rat MF P386 Type 2b INP to IGN DCX DG Decrease in F
Dividing Cells Ki-67 DG No Change
6 A P4–9 Rat MF P60 Dividing Cells BrdU 2 hours DG No Change
Dividing Cells Ki-67 DG No Change
Type 2b INP to Mature Granule Neuron NeuroD DG Decrease
P90 Dividing Cells BrdU P60 DG No Change
Dividing Cells Ki-67 DG No Change
Type 2b INP to Mature Granule Neuron NeuroD DG Decrease
7 A P4–9 Rat M P80 Dividing Cells BrdU DG Decrease
P50 Dividing Cells BrdU DG No Change
P50 Dividing Cells Ki-67 DG No Change
8 A E9–20 Rat M P84 GABAergic Mature Neurons NeuN and GAD67 CA3 Increase
DG Increase
Glutamatergic Mature Neuron NeuN and Glutamate CA3
DG
Decrease
Decrease
9 A E7-E17 Mouse MF P56 Type 2b INP to Immature Granule Neuron DCX DG Decrease
Dividing Cells Ki-67 DG No Change
10 A E1–21 Rat M P60–65 Dividing Cells BrdU GCL No Change
Hilus No Change
P81–86 BrdU P60–65 GCL No Change
Hilus No Change
11 M E5.5–E17.5 Rat M P120 CB1-positive Boutons CB1R CA1 Increase
12 A E1–21 Rat F P60–65 Dividing Cells BrdU GCL No Change
P81–86 Dividing Cells BrdU P60–65 GCL No Change
0- to 3-week-old Glia GFAP/BrdU P60–65 GCL No Change
0- to 3-week-old Mature Granule Neurons NeuN/BrdU P60–65 GCL No Change
13 M E10.5–E18.5 Mouse MF P30 Caudal Ganglionic
Eminence–derived Interneurons
GFP (5HT3AR-GFP transgenic line) DG/Hilar Border Decrease
Medial Ganglionic
Eminence–derived Interneurons
GFP (NKX2.1-cre: RCE-GFP transgenic
line)
DG/Hilar Border No Change

CA1, cornu ammonis area 1; CA2, cornu ammonis area 2; CA3, cornu ammonis area 3; DG, dentate gyrus; GABA, gamma-aminobutyric acid; GCL, granule cell layer; IGN, Immature granule neurons; INP, Immature Neural Progenitor.

Marker purposes are as follows: BrdU, bromodeoxyuridine, a thymidine analogue that labels DNA synthesis; CB1R, cannabinoid receptor type 1; DCX, doublecortin, a neuronal migration protein; GAD67, glutamate decarboxylase 67 kilodalton isoform; GFP, green fluorescent protein; Ki-67, antigen Ki-67, a marker of proliferation; NeuN, neuronal nuclei, a mature neuron marker; NeuroD, neurogenic differentiation factor 2, a marker of type 2b immature up to mature granule neurons; Venus-VGAT, a transgenic construct that labels GABAergic neurons.

HHS Vulnerability Disclosure